News

Previous Phase I and proof of concept studies of ganaxolone have demonstrated safety and efficacy in refractive epilepsy. The ganaxolone program currently consists of four clinical studies, one

The National Comprehensive Cancer Network (NCCN) studies will evaluate Abraxane in the treatment of breast, non-small cell lung, head and neck, melanoma and ovarian cancers. The clinical research

According to the company, these handpieces expand the capabilities of the Fraxel re:pair laser system, providing physicians with a complete skin resurfacing and surgical treatment option. As part

While there is no finding that Lilly has violated any provision of the state laws under which the investigations were conducted, the company said that it will pay

Medelis Europe delivers complete oncology drug development services from preclinical through Phase III. The European, US and Asian sponsors looking to bring drugs to the US and European

The terms of the deal included $450,000 in cash and a five-year warrant to purchase 750,000 shares of HepaLife’s common stock. Arbios has received $250,000 at the closing

HairDX said that it will soon begin recruiting post menopausal women as patients for the study. Women who qualify for the study will undergo genetic screening. If they

The company said that the 30,000sqft facility almost doubles its membrane production capabilities in Ireland. The new $83 million dollar membrane casting facility is expected to produce a

The single award contract has a five-year base period of performance for an estimated value of $4.1 million if all options are exercised. Under the new contract, Bridge